Institute of Natural Medicine, University of Toyama, Sugitani, Toyama 930-0194, Japan.
Biol Pharm Bull. 2010;33(6):1077-81. doi: 10.1248/bpb.33.1077.
The effects of heat-processed ginseng (HPG) and ginsenoside 20(S)-Rg(3) on the progression of renal damage in type 2 diabetic rats were investigated. Twenty-two-week-old male Otsuka Long-Evans Tokushima Fatty (OLETF) rats were divided into 4 orally administered groups: vehicle (diabetic control), HPG water extract (100 mg/kg) and 20(S)-Rg(3) (5, 10 mg/kg). Non-diabetic Long-Evans Tokushima Otsuka (LETO) rats were used as a normal group. OLETF rats showed markedly higher blood glucose, triglyceride, and total cholesterol levels than those of LETO rats. The elevated blood glucose level of OLETF rats was significantly lowered by 20(S)-Rg(3) administration. The elevated serum triglyceride and total cholesterol levels were significantly reduced by the administrations of HPG and 20(S)-Rg(3). The serum levels of thiobarbituric acid-reactive substance, an index of lipid peroxidation, were markedly increased in OLETF compared to LETO rats, but it was significantly reduced by HPG and 20(S)-Rg(3) administrations. The urinary protein level, an indicator of advanced diabetic nephropathy, of OLETF rats was 4.4 times higher than in LETO rats, but it was reduced significantly by the administrations of HPG and 20(S)-Rg(3). Creatinine clearance of OLETF rats was significantly increased after HPG and 20(S)-Rg(3) administrations. The elevation of inducible nitric oxide synthase and N(epsilon)-(carboxymethyl)lysine protein expressions in renal tissues of OLETF rats was prevented by 20(S)-Rg(3) administration. This study provides scientific evidence that 20(S)-Rg(3) prevents the progression of renal damage and dysfunction in type 2 diabetic rats via inhibiting oxidative stress and advanced glycation endproduct formation.
研究了炮制人参(HPG)和人参皂苷 20(S)-Rg(3)对 2 型糖尿病大鼠肾脏损伤进展的影响。将 22 周龄雄性 Otsuka Long-Evans Tokushima Fatty (OLETF) 大鼠分为 4 个口服给药组:载体(糖尿病对照)、HPG 水提取物(100 mg/kg)和 20(S)-Rg(3)(5、10 mg/kg)。非糖尿病 Long-Evans Tokushima Otsuka (LETO) 大鼠被用作正常组。与 LETO 大鼠相比,OLETF 大鼠的血糖、甘油三酯和总胆固醇水平明显升高。20(S)-Rg(3)给药显著降低 OLETF 大鼠的高血糖水平。HPG 和 20(S)-Rg(3)的给药显著降低了升高的血清甘油三酯和总胆固醇水平。与 LETO 大鼠相比,OLETF 大鼠的血清丙二醛反应性物质(脂质过氧化的指标)水平显著升高,但 HPG 和 20(S)-Rg(3)的给药显著降低了该水平。OLETF 大鼠的尿蛋白水平(晚期糖尿病肾病的指标)比 LETO 大鼠高 4.4 倍,但 HPG 和 20(S)-Rg(3)的给药显著降低了该水平。OLETF 大鼠的肌酐清除率在 HPG 和 20(S)-Rg(3)给药后显著升高。20(S)-Rg(3)给药可预防 OLETF 大鼠肾组织诱导型一氧化氮合酶和 N(epsilon)-(羧甲基)赖氨酸蛋白表达的升高。本研究提供了科学证据,表明 20(S)-Rg(3)通过抑制氧化应激和晚期糖基化终产物形成,防止 2 型糖尿病大鼠的肾脏损伤和功能障碍进展。